Outcomes of the Indonesian Chronic Disease Management Program (PROLANIS) in Patients with Hypertension During the COVID-19 Pandemic in Rural Areas: A Preliminary Evaluation Study

Sovia Salamah; Asiyah Nida Khafiyya; Ristra Ramadhani; Mega Rizkya Arfiana; Ibrahim Syamsuri; Novia Nurul Faizah; David Nugraha; Bustanul Arifin; Firas Farisi Alkaff

doi:10.12659/MSM.939797

12 May 2023 : Clinical Research

Outcomes of the Indonesian Chronic Disease Management Program (PROLANIS) in Patients with Hypertension During the COVID-19 Pandemic in Rural Areas: A Preliminary Evaluation Study

Sovia Salamah

^12ACDEF, Asiyah Nida Khafiyya^3DEF, Ristra Ramadhani

^4ABE, Mega Rizkya Arfiana^5BE, Ibrahim Syamsuri

^6BE, Novia Nurul Faizah^5BE, David Nugraha

^5EF, Bustanul Arifin

^78DE*, Firas Farisi Alkaff

^29ACE

DOI: 10.12659/MSM.939797

Med Sci Monit 2023; 29:e939797

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Six-month routine follow-up evaluation of study participants stratified based on their age.

Evaluated parameters	Age <60 years oldN=39			Age ≥60 years oldN=52
Evaluated parameters	T0	T1	T2	T0	T1	T2
BMI in Kg/m, median [IQR]	23.8 [22.1–25.8]	23.8 [22.2–26.4]	23.9 [22.2–25.7]=0.071	23.0 [20–24.4]	22.9 [20.3–24.2]	22.1 [20.3–24]=0.625
SBP in mmHg, median [IQR]	130 [120–140]	130 [120–144]	130 [120–140]	130 [120–140]	140 [130–150]	140 [130–157]
DBP in mmHg, median [IQR]	80 [70–90]	80 [73–90]=0.163	80 [70–90]=0.116	80 [80–90]	85 [80–90]	81 [79–90]=0.392
TC in mg/dl, mean±SD	212±39	216±40=0.442	214±44=0.724	204±44	218±41	199±39=0.425
LDL in mg/dl, mean±SD	138±37	134±37=0.504	133±43=0.575	125±42	134±34	120±34=0.391
HDL in mg/dl, median [IQR]	55 [49–62]	58 [50–68]=0.634	45 [41–51]	54 [47–65]	56 [48–66]=0.923	44 [–]³⁷
TG in mg/dl, median [IQR]	133 [105–194]	129 [107–188]=0.238	139 [94–183]=0.655	152 [103–209]	151 [98–213]=0.272	146 [100–200]=0.158
eGFR in ml/min/1.73 m, mean±SD	87.9±20	84.8±20.6=0.267	82.2±21.6=0.116	75.5±16.2	69.2±19.9	69.6±19.1
BMI – body mass index; DBP – diastolic blood pressure; eGFR – estimated glomerular filtration rate based on CKD-EPI equation; HDL – high-density lipid; LDL – low-density lipid; TC – total cholesterol; TG – triglyceride; T0 – 6-month routine evaluation conducted in December 2019; T1 – 6-month routine evaluation conducted in June 2020; T2 – 6-month routine evaluation conducted in December 2020. Paired t-test was used for normally distributed data and Wilcoxon-signed rank test was used for skewed data.

Back to the Article

Outcomes of the Indonesian Chronic Disease Management Program (PROLANIS) in Patients with Hypertension During the COVID-19 Pandemic in Rural Areas: A Preliminary Evaluation Study

Your Privacy